X Bioscience PCL, formerly WOW Factor Public Company Limited, is a Thailand-based company. The Company is engaged in the business of investments. The Company is engaged in the food business with services delivering food experience of various nationalities to consumers in Thailand.

Employees

399

Sector

Financial & Commodity Market Operators

More about the company

Quotes

Date	Price	Change	Volume
26-09-03	THB 0.0700	0.00%	13,736,836
26-09-02	THB 0.0700	0.00%	1,882,610
26-09-01	THB 0.0700	+16.67%	128,541
26-08-31	THB 0.0600	0.00%	1,644,319
26-08-28	THB 0.0600	-14.29%	278,400

End-of-day quote Thailand S.E.

More quotes

End-of-day quote Thailand S.E. 2026-09-03			5-day change	1st Jan Change
0.0700 ^THB	0.00%		0.00%	-58.82%

08-16	X Bioscience Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-20	X Bioscience Reports Higher Impairment Charges in Q1	MT

Market Cap	851M 25.86M 22.25M 20.88M 19.1M 35.66M 2.44B 35.94M 247M 96.2M 1.25B 97.12M 95M 4.02B	P/E 2024	-2.62x	P/E 2025	-0.15x
Enterprise Value	1.09B 33.02M 28.41M 26.66M 24.39M 45.53M 3.12B 45.89M 315M 123M 1.6B 124M 121M 5.14B	EV / Sales 2024	4.31x	EV / Sales 2025	3.2x
Free-Float	8.16%	Yield 2024 *	-	Yield 2025	-

08-16	X Bioscience Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-20	X Bioscience Reports Higher Impairment Charges in Q1	MT
07-16	X Bioscience Public Company Limited Announces CEO Changes	CI
07-16	X Bioscience Public Company Limited Announces Executive Changes and Restructure of Executive Committees	CI
07-15	X Bioscience Subsidiary Disposes of Entire Stake in Eastern Cuisine (Thailand)	MT
07-07	X Bioscience Public Company Limited Approves Address Change	CI
06-02	X Bioscience Public Company Limited Announces Appointment of Ramjai Sriporamin to Chief Financial Officer, Effective June 1, 2026	CI
06-02	X Bioscience Public Company Limited Announces Board Changes	CI
05-17	X Bioscience says Q1 2026 net loss widens to THB 336.5 million from loss THB 52.8 million	RE
05-17	X Bioscience Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-17	X Bioscience Public Company Limited announced a financing transaction	CI
05-05	X Bioscience Public Company Limited Announces Resignation of Phurit Wongkham as Chief Operating Officer ? Food Division, Effective May 1, 2026	CI
04-27	X Bioscience appoints Ramjai Sriporaminas as CFO (acting)	RE

Current month	+16.67%
1 month	-12.50%
3 months	-12.50%
6 months	+40.00%
Current year	-58.82%

Wow Factor Stock

Stocks

XBIO

TH0753C10Z00

Financial & Commodity Market Operators

Valuation : Wow Factor

Chart: Wow Factor

Latest news : Wow Factor

Quotes and Performance

Price Extremes

Managers and Directors : Wow Factor

Other Financial & Commodity Market Operators

Financials

Company Profile

Quotes

1 week	0.06	0.08
1 month	0.06	0.09
Current year	0.04	0.18
1 year	0.04	2.87
3 years	0.04	6.79
5 years	0.04	35.35
10 years	0.04	147

Manager	Title	Age	Since
Amnart Lertpresertwong CEO	Chief Executive Officer	54	2026-07-31
Ramjai Sriporamin DFI	Director of Finance/CFO	-	2026-04-26
Anucha Ritpakdee CTO	Chief Tech/Sci/R&D Officer	-	2014-04-30

Director	Title	Age	Since
Saowanee Khaoubol BRD	Director/Board Member	51	2022-05-12
Phurit Wongkham BRD	Director/Board Member	40	2026-02-24
Sarayut Rueangsuwan BRD	Director/Board Member	43	2025-05-15

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WOW FACTOR	0.00%	0.00%	-97.44%	-98.68%	25.67M
INTERCONTINENTAL EXCHANGE, INC.	+4.27%	+2.08%	-6.02%	+40.66%	88.62B
HONG KONG EXCHANGES AND CLEARING LIMITED	-0.25%	-4.13%	-9.06%	+32.70%	65.18B
DEUTSCHE BÖRSE AG	+1.79%	-1.05%	+16.26%	+72.64%	58.28B
LONDON STOCK EXCHANGE GROUP PLC	+3.85%	+2.42%	-2.16%	+8.83%	55.97B
NASDAQ, INC.	+3.12%	-0.64%	+5.27%	+90.05%	53.51B
SINGAPORE EXCHANGE LIMITED	+0.20%	-2.23%	+51.98%	+159.61%	20.98B
EURONEXT N.V.	+1.76%	-2.18%	+16.58%	+139.38%	18.68B
B3 S.A. - BRASIL, BOLSA, BALCÃO	+14.12%	+10.30%	+33.98%	+32.85%	16.9B
TMX GROUP LIMITED	+2.11%	-0.88%	+0.17%	+84.28%	10.55B
Average	+3.10%	+1.31%	+0.96%	+56.23%	38.87B
Weighted average by Cap.	+2.95%	-0.62%	+5.04%	+58.34%

	2024	2025
Net sales	319M 9.7M 8.34M 7.83M 7.16M 13.37M 917M 13.48M 92.61M 36.07M 468M 36.41M 35.62M 1.51B	130M 3.94M 3.39M 3.18M 2.91M 5.43M 372M 5.47M 37.61M 14.65M 190M 14.79M 14.47M 613M
Net income	-260M -7.9M -6.8M -6.38M -5.84M -10.9M -747M -10.98M -75.49M -29.4M -382M -29.68M -29.03M -1.23B	-469M -14.24M -12.25M -11.5M -10.52M -19.63M -1.35B -19.79M -136M -52.97M -688M -53.48M -52.31M -2.22B
Net Debt	345M 10.49M 9.03M 8.47M 7.75M 14.46M 992M 14.58M 100M 39.02M 507M 39.39M 38.53M 1.63B	236M 7.16M 6.16M 5.78M 5.29M 9.87M 677M 9.95M 68.38M 26.63M 346M 26.88M 26.3M 1.11B